Novartis breaks ground on flagship manufacturing hub in North Carolina

Core Points - Novartis has commenced construction on a new manufacturing hub in North Carolina, which will span over 700,000 square feet [1][4] - The project includes new facilities in Morrisville and Durham, along with the expansion of an existing facility, expected to create 700 direct jobs and over 3,000 indirect jobs by 2030 [2][4] - This initiative is part of Novartis' broader $23 billion investment in US infrastructure over the next five years [2][9] Investment and Economic Impact - The new manufacturing hub is anticipated to open between 2027 and 2028, marking a significant investment in the US market [5][6] - The expansion reflects Novartis' commitment to domestic production of key medicines, enhancing the supply chain for US patients [4][7] - The project is expected to bolster the local economy and create high-paying jobs, reinforcing North Carolina's position in the life sciences sector [5][9] Regulatory and R&D Developments - Novartis has achieved five FDA approvals in various therapeutic areas, demonstrating its commitment to innovation [8] - The company plans to establish a $1.1 billion biomedical research hub in San Diego, complementing its existing research facilities [8] - Investments in manufacturing capabilities include new facilities in Florida and Texas, alongside expansions in Indiana and New Jersey [8]